OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Brilacidin, a COVID-19 Drug Candidate, Exhibits PotentIn VitroAntiviral Activity Against SARS-CoV-2
Allison Bakovic, Kenneth Risner, Nishank Bhalla, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 14
Allison Bakovic, Kenneth Risner, Nishank Bhalla, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 14
Showing 14 citing articles:
Antimicrobial Peptides: A Potent Alternative to Antibiotics
Mariam Rima, Mohamad Rima, Ziad Fajloun, et al.
Antibiotics (2021) Vol. 10, Iss. 9, pp. 1095-1095
Open Access | Times Cited: 244
Mariam Rima, Mohamad Rima, Ziad Fajloun, et al.
Antibiotics (2021) Vol. 10, Iss. 9, pp. 1095-1095
Open Access | Times Cited: 244
Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides
Xin Li, Siyao Zuo, Wang Bin, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2675-2675
Open Access | Times Cited: 115
Xin Li, Siyao Zuo, Wang Bin, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2675-2675
Open Access | Times Cited: 115
Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
Miray Tonk, Daniel Růžek, Andreas Vilcinskas
Viruses (2021) Vol. 13, Iss. 5, pp. 912-912
Open Access | Times Cited: 32
Miray Tonk, Daniel Růžek, Andreas Vilcinskas
Viruses (2021) Vol. 13, Iss. 5, pp. 912-912
Open Access | Times Cited: 32
Emerging small molecule antivirals may fit neatly into COVID-19 treatment
Caroline Fenton, Susan J. Keam
Drugs & Therapy Perspectives (2022) Vol. 38, Iss. 3, pp. 112-126
Open Access | Times Cited: 20
Caroline Fenton, Susan J. Keam
Drugs & Therapy Perspectives (2022) Vol. 38, Iss. 3, pp. 112-126
Open Access | Times Cited: 20
Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform
Kaushik Chakravarty, Victor Antontsev, Maksim Khotimchenko, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 1912-1912
Open Access | Times Cited: 19
Kaushik Chakravarty, Victor Antontsev, Maksim Khotimchenko, et al.
Molecules (2021) Vol. 26, Iss. 7, pp. 1912-1912
Open Access | Times Cited: 19
Host Defence Peptides: A Potent Alternative to Combat Antimicrobial Resistance in the Era of the COVID-19 Pandemic
Waqas Ali, Ahmad Elsahn, Darren Shu Jeng Ting, et al.
Antibiotics (2022) Vol. 11, Iss. 4, pp. 475-475
Open Access | Times Cited: 14
Waqas Ali, Ahmad Elsahn, Darren Shu Jeng Ting, et al.
Antibiotics (2022) Vol. 11, Iss. 4, pp. 475-475
Open Access | Times Cited: 14
Theta-Defensins to Counter COVID-19 as Furin Inhibitors: In Silico Efficiency Prediction and Novel Compound Design
Manica Negahdaripour, Mohammad Reza Rahbar, Zahra Mosalanejad, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 10
Manica Negahdaripour, Mohammad Reza Rahbar, Zahra Mosalanejad, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 10
Short Antimicrobial Peptides: Therapeutic Potential and Recent Advancements
Lalita Sharma, Gopal Singh Bisht
Current Pharmaceutical Design (2023) Vol. 29, Iss. 38, pp. 3005-3017
Closed Access | Times Cited: 4
Lalita Sharma, Gopal Singh Bisht
Current Pharmaceutical Design (2023) Vol. 29, Iss. 38, pp. 3005-3017
Closed Access | Times Cited: 4
A Comprehensive Overview On The Most Recent Trends In Covid-19 Diagnosis, Treatment Options And Vaccine Development Status
Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel
(2021) Vol. 001, Iss. 01
Closed Access | Times Cited: 6
Jayendrakumar Patel, Shalin Parikh, Shwetaben Patel
(2021) Vol. 001, Iss. 01
Closed Access | Times Cited: 6
Search for novel Plasmodium falciparum PfATP4 inhibitors from the MMV Pandemic Response Box through a virtual screening approach
Keerthy Reghunandanan, T P Akhila, Nandini Krishnan, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6200-6211
Closed Access | Times Cited: 2
Keerthy Reghunandanan, T P Akhila, Nandini Krishnan, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6200-6211
Closed Access | Times Cited: 2
Review of studies on SARS-CoV-2 infection inhibitors
Aleksander Michalski, Patrycja Wójcicka, Agata Bielawska-Drózd, et al.
Annals of Agricultural and Environmental Medicine (2021) Vol. 28, Iss. 4, pp. 541-550
Open Access | Times Cited: 4
Aleksander Michalski, Patrycja Wójcicka, Agata Bielawska-Drózd, et al.
Annals of Agricultural and Environmental Medicine (2021) Vol. 28, Iss. 4, pp. 541-550
Open Access | Times Cited: 4
Antimicrobial Peptides from Frogs of the Glandirana Genus
Frederick Harris, David A. Phoenix, Sarah R. Dennison
Biologics (2024) Vol. 4, Iss. 4, pp. 444-507
Open Access
Frederick Harris, David A. Phoenix, Sarah R. Dennison
Biologics (2024) Vol. 4, Iss. 4, pp. 444-507
Open Access
Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19)
Victor Hsue, Kyohei Itamura, Arthur W. Wu, et al.
Advances in experimental medicine and biology (2021), pp. 169-189
Closed Access | Times Cited: 1
Victor Hsue, Kyohei Itamura, Arthur W. Wu, et al.
Advances in experimental medicine and biology (2021), pp. 169-189
Closed Access | Times Cited: 1
COVID-19 UK Social Media Dataset for Public Health Research: Methodology for Collection and Processing
Richard Plant
arXiv (Cornell University) (2021)
Closed Access
Richard Plant
arXiv (Cornell University) (2021)
Closed Access
